FDA Commissioner Marty Makary Resigns Under Pressure
On Tuesday, President Donald Trump announced the resignation of Marty Makary from his role as Commissioner of the U.S. Food and Drug Administration. This decision follows mounting pressure from influential Republicans, anti-abortion advocates, and commentary from The Wall Street Journal. Makary's tenure was marked by conflicts with high-ranking officials in both the White House and the Department of Health and Human Services. Until a successor is appointed, Kyle Diamantas, currently the FDA's Deputy Commissioner for Food, will assume the role. Trump noted Makary's contributions while acknowledging his recent challenges within the administration.
Key facts
- Marty Makary resigned as FDA Commissioner on Tuesday.
- President Donald Trump announced the resignation.
- Pressure came from Republicans, anti-abortion groups, and The Wall Street Journal's editorial board.
- Makary clashed with White House and HHS officials.
- Kyle Diamantas will serve as acting FDA Commissioner.
- Trump had signed off on a plan to fire Makary on Friday.
- No permanent replacement has been found yet.
- The resignation is the latest leadership change at the health department.
Entities
Institutions
- US Food and Drug Administration
- White House
- Department of Health and Human Services
- The Wall Street Journal
Locations
- United States